An IHC stained image of tumor.
An immunohistochemically stained image showcasing tumor tissue.
The image presents tumor tissue visualized through IHC staining.
A histological section stained using IHC, highlighting tumor structures.
An IHC-stained tissue sample displaying tumor morphology.
Tumor cells are observed in this IHC-stained histopathology image.
A high-resolution IHC-stained section highlighting tumor tissue.
This image captures tumor structures stained using immunohistochemical techniques.
An IHC-prepared sample showing tumor tissue distribution.
The image provides an IHC-based visualization of tumor architecture.
A microscopic view of tumor regions stained using IHC markers.

An IHC image of Tumor stained using the CDK4 biomarker.
The image presents tumor tissue stained with the CDK4 biomarker using IHC techniques.
CDK4-stained tumor structures are visualized in this IHC micrograph.
An IHC-stained section highlights tumor tissue marked by CDK4.
CDK4-positive staining is observed in tumor tissue in this IHC-stained sample.
The immunohistochemistry image features tumor tissue with CDK4 expression.
This IHC-stained tissue section reveals tumor structures marked with CDK4.
An IHC-stained micrograph of tumor tissue exhibiting CDK4 positivity.
The presence of CDK4-expressing cells is confirmed in tumor tissue through IHC staining.
The image presents tumor structures stained with the CDK4 biomarker in an IHC tissue section.
A microscopic view of tumor tissue showing CDK4-positive staining through IHC techniques.

CDK4-stained tumor cells observed under the microscope.
Tumor cells with CDK4 staining are visible under microscopic examination.
The image shows tumor tissue with CDK4-positive cells observed through microscopy.
CDK4-stained tumor cells appear in the image, confirming biomarker expression.
A microscopic view captures tumor cells with CDK4 immunostaining.
CDK4 expression in tumor cells is observed under the microscope, marking biomarker localization.
The image highlights CDK4-positive tumor cells identified through immunohistochemistry.
A high-magnification view presents tumor cells stained for CDK4, confirming marker expression.
CDK4-stained tumor sections show biomarker expression at the cellular level.
The presence of CDK4-stained tumor cells is visible in this microscopic IHC image.
CDK4-positive tumor cells are distinctly marked in this microscopic analysis.

Tumor tissue featuring distinct CDK4-positive staining, emphasizing nuclear localization of the biomarker.
The image highlights tumor tissue with distinct nuclear CDK4-positive staining.
CDK4 expression in tumor cells appears strongly localized to the nucleus.
Tumor tissue exhibits clear CDK4 nuclear staining, confirming biomarker activity.
A distinct nuclear staining pattern for CDK4 is observed in tumor tissue.
CDK4-positive staining in tumor cells is prominently localized in the nucleus.
The image presents tumor cells with nuclear CDK4 staining, marking cell cycle activity.
A strong CDK4 signal is detected in tumor cell nuclei, supporting its proliferative role.
Tumor structures display nuclear CDK4 staining, confirming its involvement in growth regulation.
The presence of CDK4-positive staining in the nuclei of tumor cells is evident.
Nuclear-localized CDK4 staining highlights its function in tumor cell proliferation.


Tumor sample analyzed with CDK4 staining, exhibiting nuclear expression indicative of CDK4 activity and its association with cellular proliferation markers.
The tumor sample exhibits nuclear CDK4 staining, suggesting its role in cell proliferation.
CDK4 expression in tumor cells is observed through nuclear staining, marking its activity.
The image highlights nuclear CDK4 positivity in tumor cells, confirming its involvement in proliferation.
CDK4 staining in tumor tissue suggests active cell cycle progression through nuclear expression.
The presence of nuclear CDK4 staining in tumor cells marks its association with proliferation markers.
Tumor cells exhibit nuclear CDK4 staining, supporting its role in cell cycle regulation.
CDK4-positive staining in tumor nuclei suggests active engagement in growth signaling pathways.
The tumor section shows CDK4 expression in cell nuclei, indicating biomarker involvement in cell division.
A distinct nuclear staining pattern for CDK4 in tumor tissue supports its association with proliferation.
CDK4 nuclear expression in tumor cells highlights its relevance in oncogenic signaling pathways.

The Immunohistochemistry image of the tumor stained with the biomarker CDK4 exhibits a brown positive nuclear staining for CDK4 protein, as seen in the nuclei of tumor cells.
The IHC image displays strong brown nuclear staining for CDK4 in tumor cells, confirming its expression.
CDK4-positive staining appears in the nuclei of tumor cells, marked by brown immunoreactivity.
The image highlights tumor cells with brown nuclear staining, indicating CDK4 protein localization.
A distinct brown nuclear staining pattern in tumor cells confirms CDK4 positivity.
CDK4 staining in tumor tissue is observed as a brown signal concentrated in cell nuclei.
The presence of nuclear CDK4 staining in tumor cells suggests active cell cycle regulation.
The image presents brown nuclear CDK4 staining, marking tumor cells with protein expression.
Tumor cell nuclei exhibit a strong brown immunoreactive signal for CDK4.
CDK4 staining in the tumor section is localized to the nuclei, confirming biomarker presence.
A positive nuclear staining pattern for CDK4 in tumor cells highlights its role in proliferation.

The Immunohistochemistry image of the class tumor stained with the biomarker CDK4 shows a predominantly positive staining of the tumor cells with a moderate to strong intensity, indicating the presence of high levels of CDK4 protein in the tumor cells.
The IHC image reveals widespread CDK4 positivity in tumor cells, with moderate to strong staining intensity.
CDK4 expression in tumor cells appears at high levels, marked by consistent positive staining.
A predominantly positive CDK4 staining pattern is observed in tumor tissue, suggesting elevated protein expression.
Tumor cells exhibit moderate to strong CDK4 staining, confirming its significant presence.
The image presents CDK4-positive tumor cells with varying staining intensity, from moderate to strong.
CDK4 expression in tumor sections is marked by strong staining intensity, suggesting high protein levels.
A broad CDK4 staining distribution is visible in tumor tissue, confirming its abundant presence.
The tumor section shows extensive CDK4-positive staining, indicating elevated biomarker expression.
CDK4 staining intensity ranges from moderate to strong, highlighting its role in tumor cell proliferation.
A high CDK4 protein concentration is confirmed in tumor cells through strong immunohistochemical staining.


The Immunohistochemistry image of the class tumor stained with the biomarker CDK4 shows a moderate to strong positive staining of the tumor cells, indicating overexpression of the CDK4 protein.
CDK4 staining in tumor cells appears with moderate to strong intensity, confirming its overexpression.
The image highlights tumor cells with moderate to strong CDK4 positivity, suggesting increased expression.
A distinct CDK4 staining pattern in tumor tissue suggests overexpression of this cell cycle regulator.
CDK4-positive tumor cells exhibit varying intensities, from moderate to strong staining.
The presence of moderate to strong CDK4 staining in tumor tissue marks overexpression of the protein.
CDK4 immunostaining in tumor cells is prominently visible, suggesting upregulation of the biomarker.
Tumor tissue displays a high level of CDK4 expression, indicated by moderate to strong staining.
CDK4 overexpression in tumor cells is evidenced by the strong staining pattern observed in the image.
The image presents tumor cells with moderate to intense CDK4 positivity, marking increased protein levels.
A positive immunohistochemistry stain for CDK4 confirms its overexpression in tumor cells.

The Immunohistochemistry image of the class tumor stained with the biomarker CDK4 shows strong nuclear positivity, indicating overexpression of CDK4 in the tumor cells.
The image highlights strong nuclear staining for CDK4 in tumor cells, confirming its overexpression.
CDK4 overexpression in tumor tissue is indicated by strong nuclear positivity.
A high-intensity nuclear staining pattern for CDK4 is observed in tumor cells, marking increased protein levels.
The presence of strong nuclear CDK4 staining in tumor cells suggests enhanced cell cycle regulation.
CDK4-positive tumor cells exhibit intense nuclear staining, supporting its role in tumor progression.
The image presents tumor cells with robust nuclear CDK4 expression, confirming overexpression.
A strong nuclear staining reaction for CDK4 indicates upregulated expression in tumor cells.
CDK4 overexpression is evident in tumor tissue, marked by pronounced nuclear staining.
Tumor cell nuclei exhibit strong CDK4 positivity, highlighting its involvement in tumorigenesis.
A distinct nuclear staining pattern for CDK4 confirms its overexpression and potential role in tumor cell proliferation.